Allevi
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3401 Grays Ferry Ave Bldg 176, Philadelp...Phone Number
(888) 598-1438Website
www.allevi3d.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Allevi
Allevi specializes in 3D bioprinting technology, offering a range of bioprinters and bioinks that cater to researchers in tissue engineering, organ on a chip applications, and pharmaceuticals. Their products, including the Allevi 1, 2, and 3 bioprinters, are engineered for versatility, precision, and ease of use, allowing for the printing of a variety of cell lines and bioinks. Allevi's solutions support advanced applications in drug discovery, regenerative medicine, and disease modeling, making them a trusted partner in the bioprinting community. Despite discontinuing production of their bioprinters in 2023, they continue to provide essential software and materials for bioprinting research.Explore more
Allevi Org Chart
SC
Global Director, Applications & Customer Succ...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Allevi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Allevi
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Allevi has new funding data
Product Launch: Get notified when Allevi launches new products
Allevi, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Allevi has recently received funding, and reach out quickly before it becomes old news!
Check out if Allevi is spiking on competitors!
Earning: See what the market has to say on Allevi recently announced quarterly report
Click to see if Allevi had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Allevi as Masked Content
Find more new buyers
Compare Similar Companies to Allevi
Compare insights from companies similar to Allevi, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Allevi is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Allevi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Allevi.
Allevi financials insights
Gather financial insights about Allevi, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$247K
Allevi Tech Stack
A closer look at the technologies used by Allevi
Allevi News & Media
Current Developments in 3D Bioprinting for Tissue and Organ Regeneration | Allevi, Organovo Holdings, Poietis, etc
Technological developments of the 3D Bioprinters and increasing investment in R & D of stem cell & regenerative medicines are driving the demand of the market. VANCOUVER, BC, CANADA, April 13, 2022 /EINPresswire.com/ -- Technological …3D Bioprinting Market to Grow by USD 1.24 Billion During 2020-2024 | Rising Cost Efficiency and Enhanced Productivity to Boost Growth | Technavio
LONDON--(BUSINESS WIRE)-- #3dbioprinting--The 3D Bioprinting Market will grow by $ 1.24 bn during 2020-20243D Bioprinting Market Overview with Qualitative Analysis, Competitive Landscape & Forecast 2027 Key Players: Allevi Inc., Organovo Holdings, Inc., CELLINK, Aspect Biosyst
Vancouver, BC -- (SBWIRE) -- 10/19/2020 -- Technological developments of the 3D Bioprinters and increasing investment in R & D of stem cell and regenerative medicines are driving the demand of the market. Read the full press release at http://www.sbwire.com/press-releases/3d-bioprinting-market-overview-with-qualitative-analysis-competitive-landscape-forecast-2027-key-players-allevi-inc-organovo-holdings-inc-cellink-aspect-biosyst-1310634.htmAspect Biosystems raises $20 million in funding
Aspect Biosystems, a Canadian company in the biotechnology industry, is growing dynamically, conducting research on new applications for bioprinting. Recently, company representatives reported that Aspect Biosystems is starting a project to test new cancer treatments that involved major pharmaceutical companies such as Merck or GSK and scientists at McGill University in Quebec. The company has now announced that it has raised $ 20 million in funding round A. Investors include Pangea Ventures, Pa
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Allevi
Sign Up For FreeTo access detailed company insights
Allevi specializes in 3D bioprinting technology, offering a range of bioprinters and bioinks that cater to researchers in tissue engineering, organ on a chip applications, and pharmaceuticals. Their products, including the Allevi 1, 2, and 3 bioprinters, are engineered for versatility, precision, and ease of use, allowing for the printing of a vari... Read More
